Morepen Laboratories Ltd. — Capital/Financing Update 2025

Mar 31, 2025

==> picture [92 x 841] intentionally omitted <==

==> picture [80 x 73] intentionally omitted <==

==> picture [159 x 37] intentionally omitted <==

Date: 31/03/2025

To,

BSE Limited

National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288

Subject: Acquisition of common stock by Morepen Bio, Inc., a Wholly Owned Subsidiary of the Company

Ref.: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”)

Dear Sir/ Madam,

This is to inform you that the Company had received an intimation today i.e., March 31, 2025, at 6:05 pm (IST) from Morepen Bio, Inc., a Wholly Owned Subsidiary based in the U.S.A., w.r.t., acquisition of 135,000 of common stock in ICB International, Inc., a Californiabased corporation, for a total amount of USD 675,000, effective as of March 1, 2025.

Pursuant to Regulation 30(4)(i)(c), the acquisition cost mentioned above qualifies as a material event for the Company.

The details, as required under the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given under as Annexure.

Thanking you,

Yours faithfully,

For Morepen Laboratories Limited

SIGN Vipul Digitally signed by Vipul Kumar Kumar Srivastava Date: 2025.03.31 Srivastava 19:57:20 +05'30'

Vipul Kumar Srivastava Company Secretary F-12148

Encl.: a/a.

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com

==> picture [92 x 841] intentionally omitted <==

==> picture [80 x 73] intentionally omitted <==

==> picture [159 x 37] intentionally omitted <==

Annexure

Disclosure under Regulations 30 of the SEBI LODR Regulations, read with circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November 2024.

==> picture [433 x 535] intentionally omitted <==

----- Start of picture text -----

Sr. Particulars Details
a) Name of the target entity, details in brief such as ICB International, Inc., a California
size, turnover etc. Corporation.
b) Whether the acquisition would fall within related Not applicable
party transaction(s) and whether the promoter/
promoter group/ group companies have any
interest in the entity being acquired? If yes, nature
of interest and details thereof and whether the same
is done at “arm’s length”
c) Industry to which the entity being acquired belongs Biotechnology
d) Objects and impact of acquisition (including but The acquisition was made into
not limited to, disclosure of reasons for acquisition normal course of business.
of target entity, if its business is outside the main
line of business of the listed entity)
e) Brief details of any governmental or regulatory Not applicable
approvals required for the acquisition
f) Indicative time period for completion of the Not applicable
acquisition
g) Consideration - whether cash consideration or Cash, in multiple trances.
share swap or any other form and details of the
same.
h) Cost of acquisition and/or the price at which the 135,000 no. of common stock of
shares are acquired ICB International, Inc., a California
Corporation, at an aggregate sum of
USD 675,000.
i) Percentage of shareholding / control acquired and / 135,000 no. of common stock
or number of shares acquired
j) Brief background about the entity acquired in terms The target company is engaged into
of products/line of business acquired, date of the business of biotechnology.
incorporation, history of last 3 years’ turnover,
country in which the acquired entity has presence
and any other significant information (in brief)
----- End of picture text -----

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com